Search results
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 5 hours agoThe FDA is also scheduled to make a decision in September on whether to expand the approval for...
Sanofi (NASDAQ:SNY) Shares Acquired by Putnam Investments LLC
ETF DAILY NEWS· 1 day agoPutnam Investments LLC boosted its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 25.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,342,709 ...
Is Sanofi SA (NASDAQ:SNY) the Best International Pharmaceutical Dividend Stock?
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since Sanofi SA...
JD Supra: Breaking: Third Circuit Declares Mallinckrodt’s Future Royalty Payment Obligations...
JD Supra· 1 day agoOn April 25, the US Court of Appeals for the Third Circuit issued its precedential opinion in Mallinckrodt v. Sanofi-Aventis, Case No. 23-1111, reminding everyone that “creditors ...
Regeneron, Sanofi Get Expanded FDA OK for Kevzara in Polyarticular Juvenile Idiopathic Arthritis
Morningstar· 2 days agoBy Colin Kellaher Regeneron Pharmaceuticals and Sanofi have won expanded Food and Drug Administration approval of their arthritis drug Kevzara for certain patients with a ...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 6 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
The Motley Fool via AOL· 1 day agoAs AI rapidly becomes a key feature of healthcare, J&J's diverse portfolio and commitment to...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 3 days agoModerna stock toppled Monday after the biotech company said its combination Covid and flu vaccine...
Goldstein v. Denner: Delaware Court of Chancery imposes sanctions for spoliation of evidence | JD...
JD Supra· 3 days agoIn May 2017, Sanofi, S.A. expressed interest in purchasing Bioverativ, Inc. (the Company) at a share price representing a 64% premium to the trading price. The Company’s board ...
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
Zacks via Yahoo Finance· 2 days agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that the FDA has approved a...